Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Handrub Tablet Loaded with Pre- and Post-Biotic Solid Lipid Nanoparticles Combining Virucidal Activity and Maintenance of the Skin Barrier and Microbiome. | Pharmaceutics | 2023 | 38140133 | PubTator, text mining | PubMed |
| Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors. | Int J Mol Sci | 2023 | 38139209 | PubTator, text mining | PubMed |
| Oat (Avena sativa L.) Sprouts Restore Skin Barrier Function by Modulating the Expression of the Epidermal Differentiation Complex in Models of Skin Irritation. | Int J Mol Sci | 2023 | 38139104 | PubTator, text mining | PubMed |
| Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions. | Molecules | 2023 | 38138551 | PubTator, text mining | PubMed |
| Porokeratoses-A Comprehensive Review on the Genetics and Metabolomics, Imaging Methods and Management of Common Clinical Variants. | Metabolites | 2023 | 38132857 | PubTator, text mining | PubMed |
| Regulatory Ability of Lactiplantibacillus plantarum on Human Skin Health by Counteracting In Vitro Malassezia furfur Effects. | J Fungi (Basel) | 2023 | 38132754 | PubTator, text mining | PubMed |
| Immunohistochemistry in an Adult Case of Bitot's Spots Caused by Vitamin A Deficiency. | Diagnostics (Basel) | 2023 | 38132260 | PubTator, text mining | PubMed |
| Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review. | Cells | 2023 | 38132113 | PubTator, text mining | PubMed |
| Human Probiotic Lactobacillus paracasei-Derived Extracellular Vesicles Improve Tumor Necrosis Factor-α-Induced Inflammatory Phenotypes in Human Skin. | Cells | 2023 | 38132109 | PubTator, text mining | PubMed |
| A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency. | PLoS Pathog | 2023 | 38113273 | PubTator, text mining | PubMed |
| UBE2N is essential for maintenance of skin homeostasis and suppression of inflammation. | bioRxiv | 2023 | 38105982 | PubTator, text mining | PubMed |
| β-endorphin suppresses ultraviolet B irradiation-induced epidermal barrier damage by regulating inflammation-dependent mTORC1 signaling. | Sci Rep | 2023 | 38102220 | PubTator, text mining | PubMed |
| Activation and upregulation of keratinocyte and epidermal transglutaminases are associated with depletion of their substrates in psoriatic lesions. | Eur Rev Med Pharmacol Sci | 2023 | 38095377 | PubTator, text mining | PubMed |
| Bioinformatics analysis of human kallikrein 5 (KLK5) expression in metaplastic triple-negative breast cancer. | Cancer Innov | 2023 | 38090381 | PubTator, text mining | PubMed |
| Has-miR-300-GADD45B promotes melanoma growth via cell cycle. | Aging (Albany NY) | 2023 | 38070141 | PubTator, text mining | PubMed |
| Pyruvate Kinase Differentially Alters Metabolic Signatures during Head and Neck Carcinogenesis. | Int J Mol Sci | 2023 | 38068962 | PubTator, text mining | PubMed |
| Potential Role of IL-37 in Atopic Dermatitis. | Cells | 2023 | 38067193 | PubTator, text mining | PubMed |
| Comparative Transcriptome Analysis Identifies Desmoglein-3 as a Potential Oncogene in Oral Cancer Cells. | Cells | 2023 | 38067138 | PubTator, text mining | PubMed |
| Locked-in Scale: Full Manifestation of Lamellar Ichthyosis in an Adult with Serious Physical and Social Impairments. | Ann Dermatol | 2023 | 38061753 | PubTator, text mining | PubMed |
| Histological assessment of nanostructured fibrin-agarose skin substitutes grafted in burnt patients. A time-course study. | Bioeng Transl Med | 2023 | 38023713 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=10